Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan versus proton pump inhibitor therapy for Helicobacter pylori eradication
PACTR202507832291336Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Al-Azhar University. Primary endpoint: Eradication of H. pylori infection. Started Jul 2024; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202507832291336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507832291336.